Addition of Lenalidomide to Azacitidine in Higher Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study. (April 2017)

Record Type:
Journal Article
Title:
Addition of Lenalidomide to Azacitidine in Higher Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study. (April 2017)
Main Title:
Addition of Lenalidomide to Azacitidine in Higher Risk Myelodysplastic Syndromes. Long-Term Results of a Randomized Phase II Multicenter Study
Authors:
Finelli, C.
Clissa, C.
Follo, M.
Barraco, M.
Mongiorgi, S.
Avanzini, P.
Bosi, C.
Castagnari, B.
Candoni, A.
Crugnola, M.
Giannini, M.B.
Gobbi, M.
Leonardi, G.
Rigolin, G.M.
Russo, D.
Tosi, P.
Pellagatti, A.
Boultwood, J.
Cocco, L.
Cavo, M.
Abstract:
Is Part Of:
Leukemia research. Volume 55(2017)Supplement 1
Journal:
Leukemia research
Issue:
Volume 55(2017)Supplement 1
Issue Display:
Volume 55, Issue 1 (2017)
Year:
2017
Volume:
55
Issue:
1
Issue Sort Value:
2017-0055-0001-0000
Page Start:
S50
Page End:
S51
Publication Date:
2017-04
Subjects:
Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905
Journal URLs:
http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0145-2126(17)30191-1 ↗
Languages:
English
ISSNs:
0145-2126
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
439.xml